Published by Unseen Progress, an independent publisher of caregiver research. Last reviewed 2026-05-10. Part of the Parkinson's caregiver research overview.
Short answer. Parkinson's disease psychosis — visual hallucinations and delusions — affects up to 60% of people with PD over the long course of the disease (Fenelon et al., 2000; Forsaa et al., 2010). It is a feature of the disease and its treatment, not a separate mental illness. Most early hallucinations are visual, often non-threatening, and the person may retain insight. The caregiver response — calm, validating, not corrective — matters because it shapes whether the symptoms become a source of fear or remain a manageable feature of the illness (Goetz et al., 2008; Fernandez et al., 2008).
What Parkinson's psychosis actually is
Parkinson's disease psychosis (PDP) is the clinical term for the spectrum of hallucinations, illusions, and delusions that develops in many people with PD as the disease progresses, particularly when cognitive impairment is also present. It is distinct from psychosis in schizophrenia or from dementia-related psychosis in important ways:
- It is visual far more often than auditory. Roughly 80% of hallucinations in PDP are visual; auditory hallucinations are less common (Fenelon et al., 2000).
- The content is often recurrent and specific. People, animals, or shadows are the most common. The same figures often appear repeatedly.
- Insight is often preserved early. Many people know the figures are not real, particularly in the first months or years of symptoms.
- It is linked to dopaminergic medication. Levodopa, dopamine agonists, and amantadine can all provoke or worsen psychotic symptoms. Dopamine agonists are the highest-risk class.
- It is also linked to disease progression. Lewy body pathology in cortical regions, particularly visual processing areas, contributes independently. PDP is more common in people with PD dementia and in dementia with Lewy bodies.
The MDS-PDP criteria (Ravina et al., 2007) require at least one of: illusions, false sense of presence, hallucinations, or delusions; recurring or continuous for at least one month; after PD onset; not better explained by another cause.
The progression of symptoms
The literature describes a fairly consistent staircase, though individuals vary widely:
- Minor hallucinatory phenomena — passage hallucinations (a figure glimpsed in peripheral vision that vanishes when looked at directly), sense of presence (the feeling someone is in the room), visual illusions (mistaking a coat for a person). Often the earliest sign. Many people do not report these because they sound minor or embarrassing.
- Well-formed visual hallucinations with insight — full figures, animals, or scenes, often recognised as not real. The person may describe them matter-of-factly.
- Hallucinations without insight — the person believes the figures are real and may react to them.
- Delusions — fixed false beliefs, most commonly persecutory ("people are stealing from me," "my spouse is being unfaithful") or jealous (Capgras syndrome — the belief that a family member has been replaced by an imposter — is rare but recognised in PDP).
- Severe psychosis with agitation — distressing, sometimes aggressive, often associated with delirium overlay.
What the caregiver response should be
The research is consistent on what helps and what makes things worse. The intuitive responses — arguing, correcting, providing evidence — almost always make things worse. The protective responses — validation, calm, gentle redirection — are learnable.
When the person mentions hallucinations
- Acknowledge without confirming or denying. "I can see you're describing someone in the corner. I don't see them, but I believe you're seeing something." This validates the experience without confirming a false reality.
- Ask about content gently. "What do they look like? Are they bothering you?" Often the hallucinations are non-threatening (children, animals, deceased relatives) and the person is not distressed. Confirming the threat level reduces the caregiver's own anxiety.
- Do not argue or provide evidence. "There's no one there, look" almost never works and often escalates. If the person has lost insight, they cannot be reasoned out of the hallucination, and the argument itself destroys trust.
- Note the time and circumstance. Late afternoon, evening, after a medication change, during illness, in dim light — these are all common triggers. Patterns matter for treatment decisions.
When delusions appear
- Take theft and infidelity delusions seriously enough to talk to the neurologist immediately. They are common, distressing, and often respond to medication adjustments or to pimavanserin (Nuplazid), the only FDA-approved antipsychotic for PDP.
- Do not try to disprove the delusion. Showing the missing wallet, denying the affair — both intensify rather than resolve the belief.
- Reduce the conditions that feed delusions. Less ambiguity, more routine, fewer unfamiliar people in the home, consistent lighting.
- Plan for caregiver safety. Delusional content occasionally targets the caregiver directly. The literature on PDP-associated aggression is small but real; safety planning is part of standard care.
Environmental adjustments that help
- Lighting. Many hallucinations occur in low light. Brighter, more even lighting reduces frequency. Night lights in hallways and bathrooms.
- Reduce visual clutter. Patterned wallpaper, busy carpets, and visual chaos can fuel illusions.
- Mirrors. People with PDP sometimes see their own reflection as another person. Covering or repositioning mirrors helps.
- Television. TV content can blur with reality, particularly in low light or during evening hours. Reducing or relocating TV viewing is sometimes useful.
- Sleep. Poor sleep and REM sleep behaviour disorder both worsen daytime hallucinations. Addressing sleep is a first-line intervention.
What the neurologist should be doing
The American Academy of Neurology and Movement Disorder Society guidelines on PDP converge on a stepwise approach:
1. Rule out delirium. New or rapidly worsening psychosis in PD is delirium until proven otherwise. Urinary tract infection, dehydration, constipation, pneumonia, and medication interactions all cause delirium that looks like psychosis. The first action is medical workup, not antipsychotic prescription. 2. Review medications. Anticholinergics, amantadine, dopamine agonists, MAO-B inhibitors, and COMT inhibitors are reduced or discontinued in roughly that order. Levodopa is reduced last because it is the most therapeutically essential. 3. Treat sleep disorders. REM sleep behaviour disorder, insomnia, and obstructive sleep apnea all amplify daytime psychosis. 4. Consider pimavanserin. The only FDA-approved antipsychotic for PDP; works on 5-HT2A receptors and does not worsen motor symptoms. Black box warning for older patients with dementia-related psychosis. Used selectively. 5. Avoid standard antipsychotics where possible. Haloperidol, risperidone, olanzapine, and most typical and atypical antipsychotics worsen PD motor symptoms, sometimes dramatically. Quetiapine and clozapine are the safer alternatives when an antipsychotic is needed urgently and pimavanserin is not available; clozapine requires blood monitoring. 6. Treat cognitive impairment. Cholinesterase inhibitors (rivastigmine, donepezil) sometimes reduce psychosis in PDD/DLB.
Red flags that warrant urgent contact
- New psychosis appearing over hours or days — almost always delirium. Get medical assessment.
- Aggression or threats — safety planning, possible emergency assessment.
- Severe distress that does not resolve. The person believes the hallucinations are real and is terrified.
- Refusal of food, fluids, or medications because of delusions.
- Caregiver feels unsafe. Trust this signal. Call the neurologist or, if acute, emergency services.
What this is not
- Not a sign that the person is "losing their mind" in any meaningful sense — they have a neurological symptom of a neurological disease.
- Not the same as Alzheimer's-type dementia, even when cognitive symptoms are present. The mechanisms and treatments differ.
- Not a reason to stop levodopa unilaterally. Sudden levodopa withdrawal can cause neuroleptic malignant-like syndrome, which is dangerous.
- Not the caregiver's fault. Hallucinations and delusions are produced by Lewy body pathology and dopaminergic medication, not by anything the family did or did not do.
Related questions
References
- Fenelon, G., Mahieux, F., Huon, R., & Ziegler, M. (2000). Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain, 123(4), 733-745.
- Forsaa, E. B., Larsen, J. P., Wentzel-Larsen, T., et al. (2010). A 12-year population-based study of psychosis in Parkinson disease. Archives of Neurology, 67(8), 996-1001.
- Ravina, B., Marder, K., Fernandez, H. H., et al. (2007). Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS/NIMH work group. Movement Disorders, 22(8), 1061-1068.
- Fernandez, H. H., Aarsland, D., Fenelon, G., et al. (2008). Scales to assess psychosis in Parkinson's disease: critique and recommendations. Movement Disorders, 23(4), 484-500.
- Goetz, C. G., Fan, W., Leurgans, S., et al. (2008). The malignant course of "benign hallucinations" in Parkinson disease. Archives of Neurology, 63(5), 713-716.
- Bloem, B. R., Okun, M. S., & Klein, C. (2021). Parkinson's disease. The Lancet, 397(10291), 2284-2303.
- Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017). Non-motor features of Parkinson disease. Nature Reviews Neuroscience, 18(7), 435-450.
Additional reading: the Michael J. Fox Foundation hallucinations and psychosis resources; the Parkinson's Foundation PD psychosis materials; the International Parkinson and Movement Disorder Society clinical practice guidelines; the American Academy of Neurology PD practice parameters.
---
Unseen Progress publishes long-form caregiver research and builds research-backed daily trackers for the families covered. See the full Parkinson's caregiver research overview for the complete framework.